ATC Group: J05AX25 Baloxavir marboxil

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Antiinfectives for systemic use
2
Antivirals for systemic use
3
Direct acting antivirals
4
Other antivirals
5
J05AX25
Baloxavir marboxil

Active ingredients

Active Ingredient
Description

Baloxavir marboxil is a prodrug that is converted by hydrolysis to baloxavir, the active form that exerts anti-influenza activity. Baloxavir acts on the cap-dependent endonuclease (CEN), an influenza virus-specific enzyme in the polymerase acidic (PA) subunit of the viral RNA polymerase complex and thereby inhibits the transcription of influenza virus genomes resulting in inhibition of influenza virus replication.

Medicines in this ATC group

Drug
Countries

Austria Finland Hong Kong Ireland Lithuania ...

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
Structured Product Labeling (SPL/PLR)
US